Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Jun'24
Jun'23
Jun'22
Jun'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025
Compare Profit and Loss Results of P & G Health Ltd
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,407.00
2,180.00
-773.00
-35.46%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,407.00
2,180.00
-773.00
-35.46%
Expenditure (Ex Depriciation)
Stock Adjustments
-12.00
11.00
-23.00
-209.09%
Raw Materials Consumed
377.00
1,098.00
-721.00
-65.66%
Power & Fuel Cost
7.00
32.00
-25.00
-78.12%
Employee Cost
222.00
381.00
-159.00
-41.73%
Operating Expenses
90.00
155.00
-65.00
-41.94%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
106.00
106.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
21.00
-55.00
76.00
138.18%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
951.00
1,895.00
-944.00
-49.82%
Operating Profit (PBDIT) excl Other Income
456.00
285.00
171.00
60.00%
Other Income
17.00
123.00
-106.00
-86.18%
Operating Profit (PBDIT)
474.00
408.00
66.00
16.18%
Interest
0.00
113.00
-113.00
-100.00%
Profit before Depriciation and Tax
473.00
294.00
179.00
60.88%
Depreciation
23.00
91.00
-68.00
-74.73%
Profit Before Taxation & Exceptional Items
449.00
203.00
246.00
121.18%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
449.00
203.00
246.00
121.18%
Provision for Tax
122.00
19.00
103.00
542.11%
Profit After Tax
326.00
183.00
143.00
78.14%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
159.00
755.00
-596.00
-78.94%
Profit Available for appropriations
486.00
939.00
-453.00
-48.24%
Appropriations
486.00
939.00
-453.00
-48.24%
Equity Dividend (%)
2050%
50%
2,000.00
Earnings Per Share
197
19.92
177.08
888.96%
Profit And Loss - Net Sales
Net Sales 1,407.97 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 456.66 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025
Profit And Loss - Interest
Interest 0.55 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 326.91 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025
